Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elobixibat Phase 3 in Chronic Idiopathic Constipation
NCT01833065Phase 3Terminated
- Sponsor
- Ferring Pharmaceuticals
- Start
- Apr 2013
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of elobixibat in chronic idiopathic constipation (CIC), sponsored by Ferring Pharmaceuticals. Started Apr 2013; status: terminated.
02
Drugs
elobixibat
03
Conditions
chronic idiopathic constipation (CIC)
Beyond the preview
Go deeper on NCT01833065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01833065.